SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

DaVitas warning that DefenCaths Medicare reimbursement could fall after the post-TDAPA transition has triggered a sharp selloff, as traders worry about pricing and revenue pressure. The community is divided between viewing the outlook as a serious risk and arguing DaVitas estimate is preliminary and the market reaction is excessive.

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.

Regeneron Pharmaceuticals, Inc.

Regenerons strong third-quarter earnings beat, supported by Eylea HD demand and Sanofi collaboration revenue tied to Dupixent, has driven a sharp breakout to multiyear highs. Traders are broadly bullish on the results, while some are watching whether the gains hold after the surge.

Shopify, Inc. is a global commerce company that provides essential internet infrastructure for commerce, offering trusted tools to start, scale, market, and run a retail business of any size. The Company's software enables merchants to run their business across all of their sales channels, including web and mobile storefronts, physical retail locations, social media storefronts and marketplaces. The Shopify platform provides merchants with a single view of their business across all of their sales channels and enables them to manage products and inventory, process orders and payments, fulfill and ship orders, build customer relationships, source products, leverage analytics and reporting and access financing, all from one integrated back office. The company was founded on September 28, 2004 and is headquartered in Ottawa, Canada.

Shopify Inc - Ordinary Shares - Class A (Sub Voting)

Shopify Inc

Positioning around Shopifys Q3 earnings is driving discussion, with traders weighing the companys growth and AI-commerce prospects against its valuation and the risk of a volatile report. The stocks sharp swings have also prompted debate over whether its recent pullback is a buying opportunity or a sign of further weakness.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

A stronger-than-expected third-quarter report and raised revenue outlook, driven by demand for Mounjaro and Zepbound, are fueling LLYs rally and analyst optimism. Traders are bullish on its GLP-1 franchise and pipeline, while some question the stocks valuation and point to lower profit guidance tied to acquisition-related charges.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TGTXs climb to a 52-week high is drawing attention amid anticipation of its Q3 report and speculation about a possible buyout; the company has not confirmed a deal, and traders also note uncertainty around the earnings date. Bulls point to BRIUMVIs growth and possible short covering, while others question whether earnings will justify the run-up.

BankrCoin (BNKR) is a cryptocurrency and operates on the Base platform. BankrCoin has a current supply of 100,000,000,000 with 99,389,999,999.99966667 in circulation. The last known price of BankrCoin is 0.00029512 USD and is up 9.48 over the last 24 hours. It is currently trading on 84 active market(s) with $2,292,823.67 traded over the last 24 hours. More information can be found at https://warpcast.com/bankr.

BankrCoin

BNKRs rally is fueling speculation, with traders citing Bankrs expanding AI-agent infrastructure and chain integrations, along with staking and protocol-funded buybacks, as potential sources of value. Sentiment is largely bullish, but some traders warn that the token remains volatile and question whether the gains can hold amid selling pressure.

Visa, Inc. engages in the provision of digital payment services. It also facilitates global commerce through the transfer of value and information among a global network of consumers, merchants, financial institutions, businesses, strategic partners, and government entities. It offers debit cards, credit cards, prepaid products, commercial payment solutions, and global automated teller machines. The company was founded by Dee Hock in 1958 and is headquartered in San Francisco, CA.

Visa Inc - Ordinary Shares - Class A

Visa Inc

Visas quarterly earnings topped expectations, but guidance for slower growth and concerns that the stock had run ahead of results are driving a sell-the-news debate. Some traders see the pullback as an overreaction to a still-resilient payments business, while others question its premium valuation.

Happen, Inc. is a U.S. digital marketplace bank focused on the Motivated Middle high FICO, high-income borrowers actively managing their financial lives. The firm’s success is fueled by advanced credit underwriting, a proprietary technology platform, and a marketplace bank model that generates compelling revenue through loan sales, net interest income, and fee-based services. It operates through the LendingClub Bank and LendingClub Corporation (Parent Only) segments. The LendingClub Bank segment is involved in the provision of a full complement of financial products and solutions, loans, leases, and deposits. The LendingClub Corporation (Parent Only) segment includes the holding company legal entity. The company was founded by Renaud Laplanche and Soulaiman Htite on October 2, 2006 and is headquartered in San Francisco, CA.

Happen Inc.

Happens Q3 results beat estimates and the company raised its full-year outlook, drawing attention to stronger originations, profitability, and credit trends. Traders are split: some see the results and buybacks as supportive, while others say the outlook is cautious and question why the share price remains weak despite the report.

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Precigen Inc

Inovios FDA accelerated approval of a competing treatment for recurrent respiratory papillomatosis has raised concerns about competition for Precigens PAPZIMEOS. Traders debate whether the rival can gain traction or whether PAPZIMEOSs full approval, commercial head start, and payer access will help it hold its position.

Transocean Ltd. engages in the provision of offshore contract drilling services for oil and gas wells. It also owns and operates offshore drilling fleets such as ultra-deepwater, harsh environment, deepwater, and midwater rigs. The company was founded in 1953 and is headquartered in Steinhausen, Switzerland.

Transocean Ltd

Attention centers on Transoceans pending all-stock Valaris merger, with traders discussing reported final Brazilian regulatory clearance and looking ahead to the deals completion and upcoming earnings. Optimism about merger synergies, rising dayrates and contract backlog competes with concerns about dilution, debt and persistent short pressure; some traders speculate that high short interest could amplify a move.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Ping An Biomedical Co., Ltd. engages in the provision of supply chain management services in the apparel industry delivering one-stop solutions to customers for a broad range of yarn products, textiles, and finished garments. It operates through the Yarns and Finished Garments segments. The company was founded by Yuk Yin Li and Sek Yan Ko in 2013 and is headquartered in Hong Kong.

Ping An Biomedical Co Ltd. - Ordinary Shares - Class A

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$5.12
Prev Close	$5.00
Open	$5.33
Dividend Yield	0.00%
50-Day Moving Average	$5.15
Beta	0.83
Avg. Volume	41,177.23
PE Ratio	N/A

52-Week High	$29.29
52-Week Low	$3.07
Market Capitalization	$14.45M
EPS (Annual)	-$3.85
Price to Book	1.42
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info

PASW Fundamentals